MRC1 and colorectal cancer: Reduced circPCLE1 expression inhibits M2 macrophage markers (IL-10, MRC1), glucose consumption, and cell proliferation in colorectal cancer, while increasing the proportion of M1 macrophage markers (TNF-, IL-6) and decreasing the CD206+ and CD168+ macrophages.